Literature DB >> 11470318

The response of neurones and glial cells to elevated copper.

N T Watt1, N M Hooper.   

Abstract

Defective copper excretion in Wilson's disease can result in increased neurological copper concentrations. This is thought to occur following exposure to increased circulating copper released from necrotic hepatocytes in a saturated liver. BU17 human glioma cells and SH-SY5Y human neuroblastoma cells were exposed to media supplemented with copper in the range 0-250 microM for periods up to 48 h to investigate this hypothesis. Copper uptake, cell growth, intracellular radical generation, and oxidative stress were measured in copper exposed cells. No increase in copper uptake or inhibition of cell growth could be measured in either cell type at any time point or copper concentration investigated. However, significant increases in radical generation (p < 0.001) could be measured in both BU17 and SH-SY5Y cells. A decreased ability to cope when the cells were exposed to additional pro-oxidants suggested that the cells were under oxidative stress with significant reductions in cell viability following exposure to both copper and ascorbic acid. These data suggest that copper sequestration does not occur in neuronal cells exposed to elevated extracellular copper concentrations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470318     DOI: 10.1016/s0361-9230(01)00506-8

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  9 in total

Review 1.  Metal toxicity, liver disease and neurodegeneration.

Authors:  Roger F Butterworth
Journal:  Neurotox Res       Date:  2010-04-06       Impact factor: 3.911

2.  MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation.

Authors:  T J Kim; I O Kim; W S Kim; J E Cheon; S G Moon; J W Kwon; J K Seo; K M Yeon
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

Review 3.  Diagnosis and treatment of Wilson's disease.

Authors:  Indu Subramanian; Zeba F Vanek; Jeff M Bronstein
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

Review 4.  Wilson disease.

Authors:  Reinhard Kitzberger; Christian Madl; Peter Ferenci
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

Review 5.  Pathophysiology and clinical features of Wilson disease.

Authors:  Peter Ferenci
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

6.  Copper Induces Apoptosis of Neuroblastoma Cells Via Post-translational Regulation of the Expression of Bcl-2-family Proteins and the tx Mouse is a Better Model of Hepatic than Brain Cu Toxicity.

Authors:  Hsien W Chan; Tianbing Liu; Giuseppe Verdile; Glenda Bishop; Ryan J Haasl; Mark A Smith; George Perry; Ralph N Martins; Craig S Atwood
Journal:  Int J Clin Exp Med       Date:  2008-01-20

7.  Copper Dependent Modulation of α-Synuclein Phosphorylation in Differentiated SHSY5Y Neuroblastoma Cells.

Authors:  Marco Greco; Chiara Carmela Spinelli; Lidia De Riccardis; Alessandro Buccolieri; Simona Di Giulio; Debora Musarò; Claudia Pagano; Daniela Manno; Michele Maffia
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

8.  Magnetic Susceptibility Changes in the Basal Ganglia and Brain Stem of Patients with Wilson's Disease: Evaluation with Quantitative Susceptibility Mapping.

Authors:  Selim Doganay; Kazim Gumus; Gonca Koc; Ayse Kacar Bayram; Mehmet Sait Dogan; Duran Arslan; Hakan Gumus; Sureyya Burcu Gorkem; Saliha Ciraci; Halil Ibrahim Serin; Abdulhakim Coskun
Journal:  Magn Reson Med Sci       Date:  2017-05-18       Impact factor: 2.471

9.  Olive (Olea europaea L.) Biophenols: A Nutriceutical against Oxidative Stress in SH-SY5Y Cells.

Authors:  Syed Haris Omar; Philip G Kerr; Christopher J Scott; Adam S Hamlin; Hassan K Obied
Journal:  Molecules       Date:  2017-10-29       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.